BRCA2 and prostate adenocarcinoma: On the other hand, Willems-Jones et al. [42] note that high-grade prostatic intraepithelial neoplasia, believed to be a precursor to prostate adenocarcinoma in some cases, does not display LOH at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.